The amylin analog petrelintide reduces body weight with ‘placebo-like’ tolerability, a phase 2 trial shows.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/petrelintide-tolerability-could-improve-glp-1-challenges-2026a1000iy7?src=rss
Author :
Publish date : 2026-06-06 16:21:00
Copyright for syndicated content belongs to the linked Source.
